Latest California Healthline Stories
Terrifying Brush With Death Drives Doctor To Fight For Patients
Dr. Rana Awdish was completing a fellowship in critical care when she became critically ill herself. Now, she helps other doctors understand the patient’s perspective.
Trump Administration Relaxes Financial Penalties Against Nursing Homes
Medicare is discouraging regional offices from levying fines for “one-time mistakes” or from using daily fines that seek to put pressure on nursing homes to make changes.
Sickle Cell Patients, Families And Doctors Face A ‘Fight For Everything’
Premature death, a dearth of treatments, mistreatment in emergency rooms and a woeful lack of funding are just a few of the problems confronting people with sickle cell disease.
Children’s Insurance, Other Health Programs Funded — For Now — In Bill
In a short-term spending bill, Congress extends money to the Children’s Health Insurance Program through March.
Medicare Penalizes Group Of 751 Hospitals For Patient Injuries
In California, 88 hospitals were penalized, including Stanford Health Care’s hospitals in Stanford and Pleasanton, the University of California-San Francisco (UCSF) Medical Center. Each hospital will have its payments reduced by 1 percent for the year.
FDA Chief Says He’s Open To Rethinking Incentives On Orphan Drugs
The FDA’s Scott Gottlieb says the agency is focused on the big picture, and he wants to know why pharma churns out drugs for some rare diseases but not for others.
Arthritis Drugs Show How U.S. Drug Prices Defy Economics
Drugs that treat rheumatoid arthritis started out costing about $10,000 a year. Ten years later, they list for more than $40,000.
Infection Lapses Rampant In Nursing Homes But Punishment Is Rare
A Kaiser Health News analysis of federal inspection records shows that nursing home inspectors labeled mistakes in infection control as serious for only 161 of the 12,056 homes they have cited since 2014.
Bonus Tucked Into GOP Tax Bill For Those Aiming To Deduct Medical Expenses
The House sought to eliminate the tax deduction, generally used by people with serious illnesses or those who need long-term care services but it was eventually restored in the final bill — and expanded.
Biosimilars, Biologics And New Legal Challenges For RA Treatments
As biosimilar products reach the market and rival more established RA treatments, the players are exploring legal challenges involving antitrust and anti-competitive behavior.